Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 10,951 | 63,590 |
| Marketable Securities | 0 | 0 | 0 | 55,766 | 287,874 |
| Other current assets | 0 | 0 | 0 | 1,320 | 0 |
| TOTAL | $0 | $0 | $0 | $68,037 | $356,383 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 4,733 | 38,165 |
| Intangibles | 0 | 0 | 0 | 0 | 11,631 |
| Other Non-Current Assets | 0 | 0 | 0 | 1,066 | 35,329 |
| TOTAL | $N/A | $N/A | $N/A | $5,799 | $85,125 |
| Total Assets | $0 | $0 | $0 | $76,829 | $441,508 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 2,838 | 9,905 |
| Accrued Expenses | 0 | 0 | 0 | 2,459 | 14,550 |
| Other current liabilities | 0 | 0 | 0 | 93 | N/A |
| TOTAL | $0 | $0 | $0 | $7,728 | $27,854 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 6 | 29,181 |
| TOTAL | $N/A | $N/A | $N/A | $2,851 | $30,195 |
| Total Liabilities | $0 | $0 | $0 | $10,579 | $58,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 45,783 |
| Retained earnings | 0 | 0 | 0 | -86,675 | -459,366 |
| Other shareholders' equity | 0 | 0 | 0 | 147,548 | 226 |
| TOTAL | $0 | $0 | $0 | $66,250 | $383,459 |
| Total Liabilities And Equity | $0 | $0 | $0 | $76,829 | $441,508 |